Investigational Drug Service Shared Resource
The Investigational Drug Service (IDS) plays a critical role in RPCI research. IDS staff members are responsible for all aspects of investigational drug management, including accountability, ordering, receiving, destruction, returns, proper storage and dispensing. IDS pharmacists provide medication counseling for patients enrolled in clinical research studies. They also provide medication reconciliation for patients in screening for a research study, and this is documented in the electronic medical record (EMR). The number and complexity of research studies, especially Phase I studies, were the driving forces behind the creation of IDS by the Department of Pharmacy and the Clinical Protocol and Data Management (CPDM) office.
Responsibilities of IDS staff include study review for SRC and IRB submission, amendment review, review of amended investigator brochures, study implementation, dispensing and sterile products preparation, and clinical services such as medication review and patient counseling. An IDS staff member is also involved with implementation of Investigator-Initiated studies in the RPCI Clinical Research Network. IDS staff members provide expert consultation for each clinical research study utilizing pharmaceutical products.
Roswell Park Cancer Institute
Investigational Drug Service
Clinical Research Center - 7 North
Elm and Carlton Streets
Buffalo, New York 14263
Monday – Friday, 7:30 a.m. – 4:30 p.m.
Core Grant Citation
This facility is funded by NCI P30CA16056. Publications should cite the Core grant in the acknowledgment section, if publications use data generated by the Core facility. Two copies of the publication acknowledging the Core grant should also be submitted to the facility at Elm & Carlton Streets, Buffalo, NY 14263.